USPTO serial 87927734
OSNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 31, 2023
- Examiner
- RADEMACHER, APRIL LUEDERS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OSNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Virginia Wolk Marino
Virginia Wolk Marino CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or pharmaceutical purposes, namely, reagents for detecting metastasis of cancer; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for medical use, namely, reagents for genetic test; reagents for medical use, namely, reagents for amplification and detection of genes; reagents for medical use, namely, lymph node solubilizing reagents; reagents for medical use, namely, reagents for protein test; reagents for medical use, namely, reagents for cancer recurrence prediction test; reagents for medical use, namely, reagents for anticancer drug sensitivity prediction test; diluents for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or clinical diagnostic use; reference control materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagents | ACTIVE | — |
| 009 | Gene amplification or detection device for scientific or research use, namely, for detecting metastasis of cancer; laboratory apparatus and instruments, namely, for genetic testing for scientific and research purposes; measuring or testing machines and instruments for analyzing blood, body fluid, tissue or other biological samples not for medical purposes | ACTIVE | — |
| 010 | Diagnostic apparatus and instruments for medical purposes, namely, for testing DNA or RNA; diagnostic or measuring apparatus and instruments for medical purposes in the nature of genetic testing apparatus and instruments, namely, gene amplification detector, cancer metastasis analyzer, cell cycle analyzer, cancer recurrence prediction testing apparatus and instruments, anticancer drug sensitivity prediction testing apparatus and instruments, sample transfer apparatus, sample container transfer apparatus, and sample rack transfer apparatus; measuring apparatus and instruments for medical purposes for analyzing genes; pipettes for medical purposes; containers for samples for in vitro diagnosis; sampling bottles for medical purposes | ACTIVE | — |
| 042 | Medical or scientific research on cancer diagnosis; medical research; providing information relating to medical research; testing, examination or research of reagents and other medicines; testing, examination or research of medical apparatus and instruments and other machines; technological advice relating to medical apparatus and instruments, laboratory apparatus and instruments, measuring or testing machines and instruments, testing apparatus and instruments, computers and other machines; rental of gene amplification or detection device for scientific or research use; rental of laboratory apparatus and instruments; rental of measuring or testing machines and instruments for medical or scientific research; all of the foregoing for use with medical and scientific research in the field of cancer diagnosis | ACTIVE | — |
| 044 | Clinical genetic testing for detecting metastasis of cancer for diagnostic or treatment purposes; clinical testing of genes in lymph node for medical purposes; providing information relating clinical testing, namely, genetic testing; medical analysis and evaluation of clinical laboratory tests results for diagnosis of cancer metastasis or other diseases; providing medical information in the field of genetic testing; rental of medical apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OSNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 3, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 3, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 3, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 3, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jun 1, 2022 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| May 20, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 20, 2022 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Nov 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 15, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 15, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 8, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 8, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 8, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 6, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 6, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 6, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 6, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 4, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 4, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 7, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 7, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 7, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2019 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 25, 2019 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 14, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 12, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 12, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 12, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 28, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 2, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 22, 2018 | NWAP | NEW APPLICATION ENTERED | — |